Joachim Aerts

Joachim Aerts

UNVERIFIED PROFILE

Are you Joachim Aerts?   Register this Author

Register author
Joachim Aerts

Joachim Aerts

Publications by authors named "Joachim Aerts"

Are you Joachim Aerts?   Register this Author

100Publications

2575Reads

25Profile Views

Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.

Ann Surg Oncol 2019 Dec 16;26(13):4222-4228. Epub 2019 Oct 16.

Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-019-07803-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864027PMC
December 2019

Current State of Dendritic Cell-Based Immunotherapy: Opportunities for Antigen Loading of Different DC Subsets?

Front Immunol 2018 3;9:2804. Epub 2018 Dec 3.

Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.02804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287551PMC
October 2019

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy.

Front Immunol 2018 5;9:2759. Epub 2018 Dec 5.

Department of Pulmonary Medicine, Erasmus MC, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.02759DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289976PMC
October 2019

Frequency of low-grade adverse events and quality of life during chemotherapy determine patients' judgement about treatment in advanced-stage thoracic cancer.

Support Care Cancer 2019 Sep 28;27(9):3563-3572. Epub 2019 Jan 28.

Department of Pulmonary Diseases, Amphia Hospital, P.O. Box 90158, 4800 RK, Breda, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-4659-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660482PMC
September 2019

Reply to K. Masuda et al.

J Clin Oncol 2019 Sep 22;37(25):2294-2295. Epub 2019 Jul 22.

Dean A. Fennell, PhD, MD, University of Leicester and University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom; Paul Taylor, MD, Wythenshawe Hospital, Manchester, United Kingdom; David Gilligan, MD, Cambridge University Hospitals National Health Service Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom; Takashi Nakano, MD, PhD, Hyogo College of Medicine, Nishinomiya, Japan; Arnaud Scherpereel, MD, PhD, Calmette Hospital, Regional University Hospital of Lille, Lille, France; Nick Pavlakis, MD, PhD, Northern Cancer Institute, St Leonards, NSW, Australia; Jan P. van Meerbeeck, MD, PhD, Universitair Ziekenuis, Antwerp, Belgium; Joachim G.J.V. Aerts, MD, PhD, Erasmus Medical College, Rotterdam, the Netherlands; Anna K. Nowak, MD, PhD, University of Western Australia and Sir Charles Gairdner Hospital, Perth, WA, Australia; Hedy Kindler, MD, University of Chicago Medical Center, Chicago, IL; and Paul Baas, MD, PhD, Netherlands Cancer Institute, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01208DOI Listing
September 2019

Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application.

J Pharm Biomed Anal 2019 Aug 17;172:175-182. Epub 2019 Apr 17.

Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2019.04.031DOI Listing
August 2019

The relation between psychological profiles and quality of life in patients with lung cancer.

Support Care Cancer 2019 Jul 1. Epub 2019 Jul 1.

ETZ Hospital (Elisabeth-TweeSteden Ziekenhuis), Tilburg, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04923-wDOI Listing
July 2019

Early-Stage NSCLC: Advances in Thoracic Oncology 2018.

J Thorac Oncol 2019 Jun 7;14(6):968-978. Epub 2019 Mar 7.

Section of Thoracic Surgery, University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534444PMC
June 2019

Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment.

Mol Ther Oncolytics 2019 Jun 27;13:67-81. Epub 2019 Mar 27.

Department of Pulmonary Medicine, Erasmus MC Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23727705193003
Publisher Site
http://dx.doi.org/10.1016/j.omto.2019.03.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475716PMC
June 2019

The clinical impact of eradication in bronchiectasis in a Dutch referral centre.

Eur Respir J 2019 Apr 11;53(4). Epub 2019 Apr 11.

Dept of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://erj.ersjournals.com/lookup/doi/10.1183/13993003.02081
Publisher Site
http://dx.doi.org/10.1183/13993003.02081-2018DOI Listing
April 2019

Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy.

Acta Oncol 2019 Jan 3;58(1):74-80. Epub 2018 Oct 3.

a Department of Radiation and Oncology , Erasmus MC-Cancer Institute , Rotterdam , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2018.1521986DOI Listing
January 2019

The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.

J Thorac Cardiovasc Surg 2019 01 12;157(1):358-361. Epub 2018 Oct 12.

Department of Thoracic Surgery, University Hospital Zurich, University Zurich, Zurich, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2018.09.107DOI Listing
January 2019

Satisfactory results of a psychometric analysis and calculation of minimal clinically important differences of the World Health Organization quality of life-BREF questionnaire in an observational cohort study with lung cancer and mesothelioma patients.

BMC Cancer 2018 Nov 26;18(1):1173. Epub 2018 Nov 26.

Department of Medical and Clinical Psychology, Centre of Research on Psychological and Somatic Disorders (CoRPS), Tilburg University, P.O. Box 90151, 5000, LE, Tilburg, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4793-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260568PMC
November 2018

Locoregional control and survival after lymph node SBRT in oligometastatic disease.

Clin Exp Metastasis 2018 10 11;35(7):625-633. Epub 2018 Jul 11.

Department of Radiation Oncology, Erasmus MC Cancer Institute, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-018-9922-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209001PMC
October 2018

Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.

Acta Oncol 2018 Aug 28;57(8):1031-1037. Epub 2018 Feb 28.

a Department of Radiation Oncology , Erasmus MC-Cancer Institute , Rotterdam , The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2018.1445285DOI Listing
August 2018

Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challenge.

Cancer Immunol Immunother 2018 08 26;67(8):1317-1324. Epub 2018 Jun 26.

Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Viale Mario Bracci n. 16, 53100, Siena, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-018-2191-3
Publisher Site
http://dx.doi.org/10.1007/s00262-018-2191-3DOI Listing
August 2018

Treatment Satisfaction of Patients With Advanced Non-Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL).

Clin Lung Cancer 2018 07 17;19(4):e503-e516. Epub 2018 Mar 17.

Department of Pulmonary Medicine, Amphia Hospital Breda, Breda, The Netherlands; Department of Pulmonary Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.03.003DOI Listing
July 2018

Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.

Front Oncol 2018 11;8:159. Epub 2018 May 11.

Department of Pathology, Erasmus Medical Center, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958181PMC
May 2018

Biomarkers in malignant mesothelioma-an unfulfilled need or a waste of resources?

J Thorac Dis 2018 Apr;10(Suppl 9):S1084-S1087

Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.03.128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949439PMC
April 2018

Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma.

Int J Mol Sci 2018 Mar 30;19(4). Epub 2018 Mar 30.

Erasmus MC Cancer Institute, Department of Pulmonary Medicine, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms19041041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979422PMC
March 2018

Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD.

Pulm Pharmacol Ther 2018 02 21;48:111-116. Epub 2017 Oct 21.

Clinic of Pulmonary Medicine, University Hospital Basel and Respiratory Cell Research, Department of Biomedicine, University of Basel, Basel, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pupt.2017.10.011DOI Listing
February 2018

High and individually variable enzymatic activity precludes accurate determination of pemetrexed, methotrexate and their polyglutamate metabolite concentrations in plasma.

J Pharm Biomed Anal 2018 Jan 14;148:89-92. Epub 2017 Sep 14.

Department of Neurology, Erasmus MC, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2017.09.014DOI Listing
January 2018

Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.

Cell Oncol (Dordr) 2017 Oct 2;40(5):511-519. Epub 2017 Jun 2.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-017-0327-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608799PMC
October 2017

Checkpoint Blockade in Lung Cancer and Mesothelioma.

Am J Respir Crit Care Med 2017 08;196(3):274-282

1 Department of Pulmonary Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201608-1755CIDOI Listing
August 2017

Opinions of lung cancer clinicians on shared decision making in early-stage non-small-cell lung cancer.

Interact Cardiovasc Thorac Surg 2017 08;25(2):278-284

Department of Cardiothoracic Surgery, Erasmus MC, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/icvts/ivx103DOI Listing
August 2017

Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors.

Cytokine Growth Factor Rev 2017 08 28;36:5-15. Epub 2017 Jun 28.

Department of Pulmonary Medicine, Erasmus Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands; Erasmus MC Cancer Institute, Erasmus Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cytogfr.2017.06.011DOI Listing
August 2017

Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences.

Cytokine Growth Factor Rev 2017 08 12;36:25-31. Epub 2017 Jul 12.

Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cytogfr.2017.07.003DOI Listing
August 2017

Is immunotherapy a viable option in treating mesothelioma?

Future Oncol 2017 08 4;13(20):1747-1750. Epub 2017 Aug 4.

Erasmus MC Cancer Institute, Department of Pulmonary Medicine, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0234DOI Listing
August 2017

Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options.

Clin Pharmacokinet 2017 07;56(7):683-688

Department of Medical Oncology, Erasmus MC Cancer InstituteErasmus University Medical Center, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-016-0503-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488129PMC
July 2017

Novel insights into mesothelioma biology and implications for therapy.

Nat Rev Cancer 2017 07;17(8):475-488

University of Leicester, Leicester LE1 9HN, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nrc.2017.42
Publisher Site
http://dx.doi.org/10.1038/nrc.2017.42DOI Listing
July 2017

Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.

Lung Cancer 2017 05 27;107:36-40. Epub 2016 Apr 27.

Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Pulmonary Medicine, Amphia Hospital, Breda, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.04.015DOI Listing
May 2017

The distress thermometer as a predictor for survival in stage III lung cancer patients treated with chemotherapy.

Oncotarget 2017 May;8(22):36743-36749

Department of Pulmonary Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.14151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482693PMC
May 2017

Immunotherapeutic strategies in non-small-cell lung cancer: the present and the future.

Immunotherapy 2017 05;9(6):507-520

Department of Pulmonary Medicine, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2016-0151DOI Listing
May 2017

Thyroid Function and Cancer Risk: The Rotterdam Study.

J Clin Endocrinol Metab 2016 12 20;101(12):5030-5036. Epub 2016 Sep 20.

Rotterdam Thyroid Center (S.R.K., L.C., R.P.P.), Department of Epidemiology (S.R.K., L.C., R.R., A.H., A.D., O.H.F., B.H.C.S., R.P.P.), Department of Internal Medicine (L.C., R.P.P.), and Department of Pulmonology (J.G.J.V.A.), Erasmus University Medical Center, 3015 GE, Rotterdam, The Netherlands; and Department of Epidemiology (A.H.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2016-2104DOI Listing
December 2016

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.

J Clin Oncol 2016 11;34(31):3740-3748

Martin Reck, LungenClinic Grosshansdorf, Airway Research Center North, Grosshansdorf; Michael Thomas, Translational Lung Research Center Heidelberg, Thoraxklinik im Universitätsklinikum Heidelberg, Heidelberg, Germany; Alexander Luft, Leningrad Regional Clinical Hospital, Leningrad, Russia; Aleksandra Szczesna, Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy w Otwocku, Otwocku, Poland; Libor Havel, Hospital Na Bulovce, Prague, Czech Republic; Sang-We Kim, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; Wallace Akerley, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Maria Catherine Pietanza, Memorial Sloan Kettering Cancer Center, New York, NY; Kathryn Gold, University of Texas MD Anderson Cancer Center, Houston, TX; Leora Horn, Vanderbilt-Ingram Cancer Center; David Spigel, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Anne Pieters, Teresa Kong Sanchez, and Justin Fairchild, Bristol-Myers Squibb, Princeton, NJ; Yi-long Wu, Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong, People's Republic of China; Christoph Zielinski, Medical University of Vienna, Vienna, Austria; Enriqueta Felip, Vall d'Hebron University Hospital, Barcelona, Spain; Joachim Aerts, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Kazuhiko Nakagawa, Kinki University Hospital, Osaka, Japan; and Paul Lorigan, the Christie NHS Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.67.6601
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.67.6601DOI Listing
November 2016

Reply to N. Singh et al.

J Clin Oncol 2016 11 31;34(33):4054. Epub 2016 Oct 31.

Roelof Wouter Frederik van Leeuwen, Erasmus University Medical Center and Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Teun van Gelder, Erasmus University Medical Center, Rotterdam, the Netherlands; Joachim G. Aerts, Erasmus Medical Center Cancer Institute, Rotterdam, and Amphia Hospital, Breda, the Netherlands; and Ron H.J. Mathijssen, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.9356DOI Listing
November 2016

Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression.

J Thorac Oncol 2016 10 12;11(10):1755-64. Epub 2016 Jul 12.

Department of Pulmonary Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands; Department of Pulmonary Medicine, Amphia Hospital, Breda, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.06.021DOI Listing
October 2016

Quality Assessment of Video Mediastinoscopy Performed for Staging in Non-Small Cell Lung Cancer.

Thorac Cardiovasc Surg 2016 Sep 28;64(6):520-5. Epub 2015 Jul 28.

Department of Surgery, Amphia Hospital, Breda, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0035-1556082DOI Listing
September 2016

A new quantification method for assessing plasma concentrations of pemetrexed and its polyglutamate metabolites.

J Pharm Biomed Anal 2016 Sep 30;128:1-8. Epub 2016 Apr 30.

Department of Neurology, ErasmusMC, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2016.04.036DOI Listing
September 2016

Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

J Clin Oncol 2016 09 18;34(26):3204-12. Epub 2016 Jul 18.

Floris Dammeijer, Lysanne A. Lievense, G.D. Marijn Veerman, Henk C. Hoogsteden, Joost P. Hegmans, Joachim G. Aerts, and Lidia R. Arends, Erasmus Medical Center, Rotterdam, The Netherlands; and Joachim G. Aerts, Amphia Hospital, Breda, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3955DOI Listing
September 2016

Immune Therapy.

Adv Exp Med Biol 2016 ;893:59-90

Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Dr. Molewaterplein 50, Rotterdam, 3015 GD, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-24223-1_4DOI Listing
May 2016

Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 Apr 8;34(12):1309-14. Epub 2016 Feb 8.

Roelof W.F. van Leeuwen, Robert Peric, Koen G.A.M. Hussaarts, Emma Kienhuis, Nikki S. IJzerman, Peter de Bruijn, Cor van der Leest, Bronno van der Holt, Joachim G. Aerts, and Ron H.J. Mathijssen, Erasmus MC Cancer Institute; Roelof W.F. van Leeuwen and Teun van Gelder, Erasmus University Medical Center, Rotterdam; Cor van der Leest and Joachim G. Aerts, Amphia Hospital, Breda; Henk Codrington, Haga Hospital, the Hague; and Jeroen S. Kloover, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.65.2560
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.65.2560DOI Listing
April 2016

Dose and Volume of the Irradiated Main Bronchi and Related Side Effects in the Treatment of Central Lung Tumors With Stereotactic Radiotherapy.

Semin Radiat Oncol 2016 Apr 21;26(2):140-8. Epub 2015 Nov 21.

Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2015.11.002DOI Listing
April 2016

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 Mar 25;34(9):953-62. Epub 2016 Jan 25.

Suresh Senan, VU Medical Center, Amsterdam; Bonne Biesma, Jeroen Bosch Hospital, 's-Hertogenbosch; and Joachim Aerts, Erasmus MC Rotterdam/Amphia Hospital Breda, Breda, the Netherlands; Anthony Brade, Princess Margaret Hospital, University of Toronto; Neill Iscoe, Eli Lilly Canada, Toronto, Ontario, Canada; Lu-hua Wang, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing; Tony Mok, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, People's Republic of China; Johan Vansteenkiste, University Hospital KU Leuven, Leuven, Belgium; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Ramaswamy Govindan, Washington University School of Medicine, Saint Louis, MO; David Gandara, University of California, Davis Health System, Sacramento, CA; Hak Choy, UT Southwestern Medical Center, Dallas, TX; Anwar Hossain, Joseph Treat, and Andrew Koustenis, Eli Lilly and Company, Indianapolis, IN; Everett Vokes, University of Chicago, Chicago, IL; Maite Martinez Aguillo, Hospital of Navarre, Irunlarrea, Pamplona; Belén Rubio-Viqueira, Hospital Universitario Quirón Madrid; and Bélen San Antonio, Eli Lilly and Company, Madrid, Spain; Conrad Lewanski, Charing Cross Hospital, London, United Kingdom; and Nadia Chouaki, Eli Lilly and Company, Neuilly-sur-Seine, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.8824DOI Listing
March 2016

Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.

Radiother Oncol 2016 Mar 15;118(3):442-6. Epub 2016 Feb 15.

Department of Radiation Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.02.011DOI Listing
March 2016

Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status.

Cancer Immunol Res 2016 Feb 11;4(2):165-72. Epub 2015 Dec 11.

Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0176DOI Listing
February 2016

Transthoracic Needle Biopsies: It's More than Just Hitting the Bull's-eye.

Authors:
Joachim G Aerts

Clin Cancer Res 2016 Jan 19;22(2):273-4. Epub 2015 Oct 19.

Department of Pulmonary Diseases, Erasmus MC Cancer Institute Rotterdam, Amphia Hospital Breda, Breda, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1999DOI Listing
January 2016

Iron deficiency anemia as initial presentation of a non-small cell lung carcinoma: A case report.

Respir Med Case Rep 2015 11;16:109-11. Epub 2015 Sep 11.

Department of Pulmonology, Amphia Hospital, Breda, The Netherlands; Department of Pulmonology, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmcr.2015.09.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681980PMC
January 2016

Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancer.

J Cancer Res Clin Oncol 2015 Aug 6;141(8):1481-91. Epub 2015 Mar 6.

Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-015-1935-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469769PMC
August 2015

Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.

Clin Lung Cancer 2015 Jul 11;16(4):282-91. Epub 2014 Dec 11.

Department of Pulmonary Diseases, TweeSteden Hospital and St. Elisabeth Hospital, Tilburg, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.12.003DOI Listing
July 2015

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

N Engl J Med 2015 Jul 31;373(2):123-35. Epub 2015 May 31.

From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.B.); the City of Hope Comprehensive Cancer Center, Duarte, CA (K.L.R.); the Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam (P.B.), Erasmus MC Cancer Institute, Rotterdam (J.G.A.), and Ziekenhuis Amphia, Breda (J.G.A.) - all in the Netherlands; the University Hospital of Perugia, Perugia (L.C.), and the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.) - both in Italy; the Department of Medical Oncology, West German Cancer Center, Universitätsklinikum Essen, and the Ruhrlandklinik, Universität Duisburg-Essen, Essen (W.E.E.E.), the Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.), and the LungenClinic Grosshansdorf, Grosshansdorf (M.R.) - all in Germany; the N.N. Blokhin Russian Cancer Research Center, Moscow (E.P.); the H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.A.); the Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland (A.P.); the University of Chicago Medicine and Biological Sciences, Chicago (E.E.V.); the Hospital Madrid Norte Sanchinarro (E.H.), the Hospital Universitario Fundación Jiménez Díaz, Madrid (M.D.), and the Hospital Universitario Virgen Del Rocío, Seville (L.P.-A.) - all in Spain; Oncology Hematology Care, Cincinnati (D.W.); the Duke University Medical Center, Durham, NC (N.R.); Massachusetts General Hospital, Boston (J.G.); Centro Internacional de Estudios Clinicos, Santiago, Chile (O.A.F.); Nemocnice Na Bulovce, Prague, Czech Republic (L.H.); Bristol-Myers Squibb, Princeton, NJ (C.B., C.T.H., B.L.); and the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1504627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681400PMC
July 2015

Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma.

Lung Cancer 2015 Jun 21;88(3):332-7. Epub 2015 Mar 21.

Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.03.013DOI Listing
June 2015

The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers.

Oncoimmunology 2015 Jun 19;4(6):e1009285. Epub 2015 Mar 19.

Thoracic Service; Department of Surgery; Memorial Sloan Kettering Cancer Center ; New York, NY, USA ; Center of Cell Engineering; Memorial Sloan Kettering Cancer Center ; New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1009285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485766PMC
June 2015

Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation.

Eur J Cancer 2015 May 5;51(7):893-903. Epub 2015 Mar 5.

Dept. of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.02.006DOI Listing
May 2015

Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer.

Radiat Oncol 2015 Apr 22;10:98. Epub 2015 Apr 22.

Department of Radiation Oncology, Erasmus MC Cancer Institute, Postbus 2040, 3000, Rotterdam, CA, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-015-0405-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465315PMC
April 2015

Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.

Int J Cancer 2015 Mar 30;136(5):E387-95. Epub 2014 Sep 30.

Netherlands Cancer Registry, Comprehensive Cancer Centre The Netherlands, Eindhoven, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29216DOI Listing
March 2015

Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study.

Int J Radiat Oncol Biol Phys 2015 Feb;91(2):337-43

Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.10.021DOI Listing
February 2015

Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.

Ann Surg Oncol 2015 Jan 25;22(1):316-23. Epub 2014 Jun 25.

Department of Cardio-Thoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-3860-xDOI Listing
January 2015

Immunomodulation in cancer.

Curr Opin Pharmacol 2014 Aug 8;17:17-21. Epub 2014 Jul 8.

Erasmus MC Cancer Institute, Department of Pulmonary Medicine, Ee 2253a, Dr. Molewaterplein 50, 3045 PE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coph.2014.06.007DOI Listing
August 2014

Immunotherapy prospects in the treatment of lung cancer and mesothelioma.

Transl Lung Cancer Res 2014 Feb;3(1):34-45

1 Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands ; 2 Department of Pulmonary Diseases, Amphia Hospital Breda, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2013.11.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367611PMC
February 2014

Biomarkers for immune checkpoint inhibitors.

Lancet Oncol 2014 Jan;15(1):e1

Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70557-6DOI Listing
January 2014